Fall Neuroscience Research Symposium 2017

Our Fall Neuroscience Research Symposium (NRS) is coming back strong this year. We are again holding the NRS Meeting at Marquis Hall at the University of Saskatchewan on November 3, 2017. Please mark your calendars and encourage your trainees to submit abstracts for evaluation by the NRS Organizing Committee. The retreat will consist of Trainee Platform and Poster Presentations, and several cash prizes will be awarded for best Poster and Oral Presenters. We will also have door prizes from sponsors at this meeting. 

This year, we have secured funding to sponsor two confirmed Keynote Speakers: 1) Dr. V. Wee Yong, CRC Tier 1 Chair in Neuroimmunology, who will be speaking to us about his latest ground-breaking research in MS and MS clinical trials from his own lab, 2) Dr. Yu Tian Wang, BC Stroke Chair and Howard Hughes Medical Institute International Scholar, will be speaking to us about GABAa-glutamate receptor cross-talk in the brain. Free registration will open after the abstract submission deadline, which includes breakfast, lunch and snacks at coffee breaks for all registered participants.

Best regards,


Francisco S. Cayabyab
Leader, Neuroscience Research Cluster
Associate Professor
Department of Surgery, College of Medicine
University of Saskatchewan
Room GD30.5 Health Science Building
107 Wiggins Road
Saskatoon SK S7N 5E5
Canada

Tel: 306-966-8191
Email: frank.cayabyab@usask.ca

 

Neuroscience Research Cluster

Seminar Series presents

 

Christopher Phenix, PhD

Department of Chemistry

University of Saskatchewan

 Date: October 26th, 2017

Place: Room GD-04 Health Sciences Building D-Wing

Time: 3:00 pm

 

“Glucocerebrosidase and PET Tracer Development for Parkinson’s Disease”

 

ABSTRACT:

Positron emission tomography (PET) is a powerful medical imaging modality with a rich history in brain research due to its ability to image the activity of enzymes and receptors important to brain function at the molecular level. The development of novel PET probes that target proteins whose activity changes early in Parkinson’s disease would be highly useful to validate novel therapeutic targets and aid in early diagnosis.  Based on a significant amount of preclinical and clinical evidence, the Michael J. Fox Foundation has recently declared lysosomal β-glucocerebrosidase (GCase) a high priority therapeutic and diagnostic target.  This seminar will provide an introduction to PET imaging as well as talk about our efforts to develop radiotracers intended to noninvasively image GCase with PET.

 

Contact: Dr. Francisco S. Cayabyab, frank.cayabyab@usask.ca, 306-966-8191